135 related articles for article (PubMed ID: 19641221)
1. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.
Van Lith LH; Oosterom J; Van Elsas A; Zaman GJ
J Biomol Screen; 2009 Oct; 14(9):1067-75. PubMed ID: 19641221
[TBL] [Abstract][Full Text] [Related]
2. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
[TBL] [Abstract][Full Text] [Related]
3. The human complement fragment receptor, C5L2, is a recycling decoy receptor.
Scola AM; Johswich KO; Morgan BP; Klos A; Monk PN
Mol Immunol; 2009 Mar; 46(6):1149-62. PubMed ID: 19100624
[TBL] [Abstract][Full Text] [Related]
4. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.
Bamberg CE; Mackay CR; Lee H; Zahra D; Jackson J; Lim YS; Whitfeld PL; Craig S; Corsini E; Lu B; Gerard C; Gerard NP
J Biol Chem; 2010 Mar; 285(10):7633-44. PubMed ID: 20044484
[TBL] [Abstract][Full Text] [Related]
5. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
[TBL] [Abstract][Full Text] [Related]
6. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
7. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
8. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
9. C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment.
Croker DE; Halai R; Kaeslin G; Wende E; Fehlhaber B; Klos A; Monk PN; Cooper MA
Immunol Cell Biol; 2014 Aug; 92(7):631-9. PubMed ID: 24777312
[TBL] [Abstract][Full Text] [Related]
10. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis.
Wang R; Lu B; Gerard C; Gerard NP
J Immunol; 2013 Oct; 191(8):4001-9. PubMed ID: 24043888
[TBL] [Abstract][Full Text] [Related]
12. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
13. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
[TBL] [Abstract][Full Text] [Related]
14. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.
Chen NJ; Mirtsos C; Suh D; Lu YC; Lin WJ; McKerlie C; Lee T; Baribault H; Tian H; Yeh WC
Nature; 2007 Mar; 446(7132):203-7. PubMed ID: 17322907
[TBL] [Abstract][Full Text] [Related]
15. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
[TBL] [Abstract][Full Text] [Related]
16. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
Johswich K; Martin M; Thalmann J; Rheinheimer C; Monk PN; Klos A
J Biol Chem; 2006 Dec; 281(51):39088-95. PubMed ID: 17068344
[TBL] [Abstract][Full Text] [Related]
17. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
Pundir P; MacDonald CA; Kulka M
J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
19. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
Kobayashi H; Narita Y; Nishida M; Kurose H
Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]